Texas Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$790K Buy
32,803
+415
+1% +$10.9K 0.26% 96
2026
Q1
$909K Sell
32,388
-1,160
-3% -$30.9K 0.34% 78
2025
Q4
$835K Sell
33,548
-270
-0.8% -$6.81K 0.3% 86
2025
Q3
$862K Sell
33,818
-2,486
-7% -$61.4K 0.33% 80
2025
Q2
$880K Buy
36,304
+1,440
+4% +$33.6K 0.35% 79
2025
Q1
$883K Sell
34,864
-704
-2% -$18.4K 0.37% 77
2024
Q4
$944K Buy
+35,568
New +$965K 0.39% 74

Other funds holding PFE

Texas Bank & Trust's PFE Position: Q2 2026 in Review

Texas Bank & Trust increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $10.9K and bringing the position to 32,803 shares worth $790K. The position accounts for 0.26% of the portfolio, ranked #96.

Texas Bank & Trust first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $944K in Q4 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Texas Bank & Trust held 32,803 shares of Pfizer worth $790K as of Q2 2026.
  • Texas Bank & Trust bought 415 Pfizer shares in Q2 2026, an estimated $10.9K.
  • Pfizer made up 0.26% of Texas Bank & Trust's portfolio in Q2 2026, its #96 holding.
  • Texas Bank & Trust first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Texas Bank & Trust's Pfizer position peaked at $944K in Q4 2024.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.